STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] CeriBell, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) reporting person Joseph S. Manni, Chief Revenue Officer, disclosed a sale of 660 shares of common stock on 08/25/2025 at a reported price of $11.58 per share. After the transaction he beneficially owns 27,761 shares directly. The filing indicates a routine insider sale with remaining meaningful ownership by the officer.

Positive
  • Reporting officer retains substantial ownership after the sale: 27,761 shares directly owned
  • Disclosure appears complete for the reported non-derivative transaction (sale amount and price provided)
Negative
  • Insider sale occurred: 660 shares disposed at $11.58, which could be interpreted as limited insider liquidity
  • No indication in this filing that the sale was pursuant to a pre-established Rule 10b5-1 plan

Insights

TL;DR: Small insider sale; continues to hold a meaningful position, so limited immediate signal to the market.

The sale of 660 shares at $11.58 represents a modest disposition relative to the reported post-transaction holding of 27,761 shares. The transaction code F indicates a sale, and the remaining direct ownership suggests ongoing alignment with shareholder outcomes rather than an exit. For investors, this is a routine insider liquidity event rather than a material shift in ownership or control.

TL;DR: Single small sale by an officer; governance signal is neutral given sustained direct ownership.

From a governance perspective, the disclosure is timely and complete for this class of securities. The officer retains substantial direct holdings after the sale, which typically mitigates concerns about insider exodus. No derivative transactions or plan-based sales are disclosed here, so there is no indication this was part of a Rule 10b5-1 plan from the information provided.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manni Joseph S.

(Last) (First) (Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CA 94085

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Revenue Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 F 660 D $11.58 27,761 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Louisa Daniels, Attorney-in-Fact for Joseph S. Manni 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ceribell (CBLL) insider Joseph Manni report?

He reported a sale of 660 shares of common stock on 08/25/2025 at a price of $11.58 per share and holds 27,761 shares after the transaction.

Does the Form 4 show derivative transactions for CBLL?

No. Table II for derivative securities contains no reported transactions in this filing.

Is the reported sale part of a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan.

How material is the sale relative to the insider's holdings?

The sale of 660 shares is small compared with the 27,761 shares retained, indicating limited change in ownership stake.

What transaction code was used on the Form 4 for this sale?

The sale is reported with transaction code F, which denotes a sale of non-derivative securities.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

428.83M
28.79M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE